MRI of blood volume with superparamagnetic iron in choroidal melanoma treated with thermotherapy

Magnetic Resonance Imaging

Volumn 22, Issue 6, 2004, Pages 779-787

  Krause, Matthias H J ^a,b   Kwong, Kenneth K ^c   Gragoudas, Evangelos S ^a   Young, Lucy H Y ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SAARLAND UNIVERSITY   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Blood volume; Choroid neoplasms; Diagnostic use; Ferric compounds; Melanoma; Nuclear magnetic resonance; Pathology; Pharmacokinetics; Physiopathology

Indexed keywords

CONTRAST MEDIUM; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; CHOROID MELANOMA; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HYPERTHERMIC THERAPY; IMAGE PROCESSING; LOW LEVEL LASER THERAPY; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RABBIT; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; TUMOR GROWTH; TUMOR LOCALIZATION;

ANIMALS; BLOOD VOLUME; CHOROID NEOPLASMS; CONTRAST MEDIA; FEMALE; FERROSOFERRIC OXIDE; HYPERTHERMIA, INDUCED; IRON; MAGNETIC RESONANCE IMAGING; MELANOMA, EXPERIMENTAL; MODELS, ANIMAL; OXIDES; RABBITS; TREATMENT OUTCOME;

ILEX COOKII; ORYCTOLAGUS CUNICULUS;

EID: 3242728793     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2004.01.052     Document Type: Article

References (48)

1. Seddon J.M., Albert D.M., Lavin P.T., Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 101:1983;1894-1899
2. Gragoudas E.S., Egan K.M., Saornil M.A., Walsh S.M., Albert D.M., Seddon J.M. The time course of irradiation changes in proton beam-treated uveal melanomas. Ophthalmology. 100:1993;1555-1560
3. Char D.H., Crawford J.B., Castro J.R., Woodruff K.H. Failure of choroidal melanoma to respond to helium ion therapy. Arch Ophthalmol. 101:1983;236-241
4. Shields J.A., Shields C.L., Eagle R.C., Lieb W.E., Stern S. Malignant melanoma associated with melanocytoma of the optic disc. Ophthalmology. 97:1990;225-230
5. Journee-de Korver J.G., Oosterhuis J.A., de Wolff-Rouendaal D., Kemme H. Histopathological findings in human choroidal melanomas after transpupillary thermotherapy. Br J Ophthalmol. 81:1997;234-239
6. Flindall R.J., Gass J.D. A histopathologic fluorescein angiographic correlative study of malignant melanomas of the choroid. Can J Ophthalmol. 6:1971;258-267
7. Leff S.R., Augsburger J.J., Shields J.A. Focal fluorescence of choroidal melanoma. Br J Ophthalmol. 70:1986;104-106
8. Cantrill H.L., Cameron J.D., Ramsay R.C., Knobloch W.H. Retinal vascular changes in malignant melanoma of the choroid. Am J Ophthalmol. 97:1984;411-418
9. Kim R.Y., Hu L.K., Foster B.S., Gragoudas E.S., Young L.H. Photodynamic therapy of pigmented choroidal melanomas of greater than 3-mm thickness. Ophthalmology. 103:1996;2029-2036
10. Mueller A.J., Bartsch D.U., Folberg R., et al. Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol. 116:1998;31-39
11. Mafee M.F. Uveal melanoma, choroidal hemangioma, and simulating lesions. Radiol Clin North Am. 36:1998;1083-1099
12. Mafee M.F., Peyman G.A., Grisolano J.E., et al. Malignant uveal melanoma and simulating lesions MR imaging evaluation. Radiology. 160:1986;773-780
13. De Potter P., Flanders A.E., Shields J.A., Shields C.L., Gonzales C.F., Rao V.M. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions. Arch Ophthalmol. 112:1994;340-348
14. Peyster R.G., Augsburger J.J., Shíelds J.A., Hershey B.L., Eagle R., Haskin M.E. Intraocular tumors evaluation with MR imaging. Radiology. 168:1988;773-779
15. Chambers R.B., Davidorf F.H., McAdoo J.F., Chakeres D.W. Magnetic resonance imaging of uveal melanomas. Arch Ophthalmol. 105:1987;917-921
16. Bond J.B., Haik B.G., Mihara F., Gupta K.L. Magnetic resonance imaging of choroidal melanoma with and without gadolinium contrast enhancement. Ophthalmology. 98:1991;459-466
17. Moonen C.T., van Zijl P.C., Frank J.A., Le Bihan D., Becker E.D. Functional magnetic resonance imaging in medicine and physiology. Science. 250:1990;53-61
18. Rosen B.R., Belliveau J.W., Chien D. Perfusion imaging by nuclear magnetic resonance. Magn Reson Q. 5:1989;263-281
19. Belliveau J.W., Kennedy D.N., McKinstry R.C., et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science. 254:1991;716-719
20. Detre J.A., Leigh J.S., Williams D.S., Koretsky A.P. Perfusion imaging. Magn Reson Med. 23:1992;37-45
21. Kim S.G. Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique application to functional mapping. Magn Reson Med. 34:1995;293-301
22. Kwong K.K., Chesler D.A., Weisskoff R.M., et al. MR perfusion studies with T1-weighted echo planar imaging. Magn Reson Med. 34:1995;878-887
23. Williams D.S., Detre J.A., Leigh J.S., Koretsky A.P. Magnetic resonance imaging of perfusion using spin inversion of arterial water. [published erratum appears in Proc Natl Acad Sci U S A 1992 May 1;89:4220] Proc Natl Acad Sci USA. 89:1992;212-216
24. Wong E.C., Buxton R.B., Frank L.R. Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling. NMR Biomed. 10:1997;237-249
25. Krause M., Kwong K.K., Xiong J., Gragoudas E.S., Young L.H. MRI of blood volume and cellular uptake of superparamagnetic iron in an animal model of choroidal melanoma. Ophthalmic Res. 34:2002;241-250
26. Shields C.L., Shields J.A., Cater J., et al. Transpupillary thermotherapy for choroidal melanoma tumor control and visual results in 100 consecutive cases. Ophthalmology. 105:1998;581-590
27. Oosterhuis J.A., Journee-de Korver H.G., Kakebeeke-Kemme H.M., Bleeker J.C. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol. 113:1995;315-321
28. Krause M.H., Xiong J., Gragoudas E.S., Young L.H. Treatment of experimental choroidal melanoma with a Nd:Yttrium-Lanthanum-Fluoride laser at 1047 nm. Arch Ophthalmol. 121:2003;357-363
29. Hu L.K., Huh K., Gragoudas E.S., Young L.H. Establishment of pigmented choroidal melanomas in a rabbit model. Retina. 14:1994;264-269
30. Pineda R., Theodossiadis P.G., Gonzalez V.H., et al. Establishment of a rabbit model of extrascleral extension of ocular melanoma. Retina. 18:1998;368-372
31. Moore A., Weissleder R., Bogdanov A. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging. 7:1997;1140-1145
32. Koeppen A.H., Borke R.C. Experimental superficial siderosis of the central nervous system. I. Morphological observations. J Neuropathol Exp Neurol. 50:1991;579-594
33. Shen T., Weissleder R., Papisov M., Bogdanov A., Brady T.J. Monocrystalline iron oxide nanocompounds (MION) physicochemical properties. Magn Reson Med. 29:1993;599-604
34. Jung C, Weissleder R, Josephson L, Bengele H, Brady TJ. Physical properties of MION-46 and AMI-227. In: Society of Magnetic Resonance Fourth Scientific meeting; 1996 April 27-May 3; New York; 1996
35. Weissleder R, inventor. United States patent 5,492,814
36. Bulte J.W., Brooks R.A., Moskowitz B.M., Bryant L.H., Frank J.A. Relaxometry and magnetometry of the MR contrast agent MION-46L. Magn Reson Med. 42:1999;379-384
37. Zimmer C., Weissleder R., Poss K., Bogdanova A., Wright S.C., Enochs W.S. MR imaging of phagocytosis in experimental gliomas. Radiology. 197:1995;533-538
38. Frank H., Weissleder R., Brady T.J. Enhancement of MR angiography with iron oxide preliminary studies in whole-blood phantom and in animals. AJR Am J Roentgenol. 162:1994;209-213
39. Daldrup H.E., Link T.M., Blasius S., et al. Monitoring radiation-induced changes in bone marrow histopathology with ultra-small superparamagnetic iron oxide (USPIO)-enhanced MRI. J Magn Reson Imaging. 9:1999;643-652
40. Weissleder R., Cheng H.C., Marecos E., Kwong K., Bogdanov A. Non-invasive in vivo mapping of tumour vascular and interstitial volume fractions. Eur J Cancer. 34:1998;1448-1454
41. Zimmer C., Wright S.C., Engelhardt R.T., et al. Tumor cell endocytosis imaging facilitates delineation of the glioma-brain interface. Exp Neurol. 143:1997;61-69
42. Roberts D.J.H., Cairnduff F., Driver I., Dixon B., Brown S.B. Tumor vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolaevulinic acid. Int J Oncol. 5:1994;763-768
43. Henderson B.W., Vaughan L., Bellnier D.A., van Leengoed H., Johnson P.G., Oseroff A.R. Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin. Photochem Photobiol. 62:1995;780-789
44. Henderson B.W., Fingar V.H. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochem Photobiol. 49:1989;299-304
45. Star W.M., Marijnissen H.P., van den Berg-Blok A.E., Versteeg J.A., Franken K.A., Reinhold H.S. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 46:1986;2532-2540
46. Nelson J.S., Liaw L.H., Orenstein A., Roberts W.G., Berns M.W. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J Natl Cancer Inst. 80:1988;1599-1605
47. Enochs W.S., Hyslop W.B., Bennett H.F., Brown R.D.d, Koenig S.H., Swartz H.M. Sources of the increased longitudinal relaxation rates observed in melanotic melanoma. An in vitro study of synthetic melanins. Invest Radiol. 24:1989;794-804
48. nd ed :1992;253-298 Mosby, St. Louis